Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: Suggestive association signals in ADRA1A

Psychiatric Genetics

Volumn 19, Issue 3, 2009, Pages 134-141

  Elia, Josephine ^a,b   Capasso, Mario ^b,e   Zaheer, Zafar ^a,f   Lantieri, Francesca ^b,c   Ambrosini, Paul ^d   Berrettini, Wade ^a   Devoto, Marcella ^b,g   Hakonarson, Hakon ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF GENOA   (Italy)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF PESHAWAR   (Pakistan)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Association study; Attention deficit hyperactivity disorder; Candidate genes; Linkage disequilibrium

Indexed keywords

CATECHOL METHYLTRANSFERASE; EXCITATORY AMINO ACID TRANSPORTER 1; PROTEIN HTR2A; PROTEIN HTR4; PROTEIN SLC6A3; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UNCLASSIFIED DRUG; ADRENERGIC RECEPTOR ALPHA(1A); ALPHA 1 ADRENERGIC RECEPTOR;

ADOLESCENT; ADRA1A GENE; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOME; GENOTYPE; HAPLOTYPE; HTR2A GENE; HTR4 GENE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PEDIGREE ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; SAMPLE; SCHOOL CHILD; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 67649198996     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32832a5043     Document Type: Article

References (91)

1. Ambrosini PJ (2000). Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J Am Acad Child Adolesc Psychiatry 39:49-58.
2. American Psychiatric Association (2004). Diagnostic and Statistical Manual of Mental Disorders. 4th ed. DSM-IV-TR (text revision). Washington, DC: American Psychiatric Association.
3. Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD, Palacio LG, et al. (2004). Attention-deficitfhyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 75:998-1014.
4. Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP, et al. (2007). Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry 164:674-677.
5. Asherson P, Zhou K, Anney RJ, Franke B, Buitelaar J, Ebstein R, et al. (2008). A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry 13:514-521.
6. Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL,
7. Monsuur AJ, et al. (2003). A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 72:1251 -1260.
8. Barkley RA, Fischer M, Smallish L, Fletcher K (2006). Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45:192-202.
9. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, et al. (2000). Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry 5:405-409.
10. Barr CL, Wigg K, Malone M, Schachar R, Tannock R, Roberts W, Kennedy JL (1999). Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am J Med Genet 88:710-713.
11. Barr CL, Wigg K, Zai G, Roberts W, Malone M, Schachar R, et al. (2001). Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C. Mol Psychiatry 6:334-337.
12. Barrett JC, Fry B, Mailer J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
13. Bellgrove MA, Domschke K, Hawi Z, Kirley A, Mullins C, Robertson IH, Gill M (2005). The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD. Exp Brain Res 163:352-360.
14. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, et al. (2005). Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet 134:67-72.
15. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, et al. (2006a). The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11:934-953.
16. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, et al. (2006b). The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11:934-953.
17. Brookes KJ, Mill J, Guindalini C, Curran S, Xu X, Knight J, et al. (2006c). A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry 63:74-81.
18. Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M (2002). Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol Psychiatry 7:913-917.
19. Buckland PR, Hoogendoorn B, Coleman SL, Guy CA, Smith SK, O'Donovan MC (2005). Strong bias in the location of functional promoter polymorphisms. Hum Mutat 26:214-223.
20. Carlsson A, Winblad B (1976). Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm 38:271-276.
21. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK (1996). The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet 98:91-101.
22. Cheuk DK, Wong V (2006). Meta-analysis of association between a catechol- O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet 36:651-659.
23. Demarest KT, Riegle GD, Moore KE (1980). Characteristics of dopaminergic neurons in the aged male rat. Neuroendocrinology 31:222-227.
24. Deupree JD, Smith SD, Kratochvil CJ, Bohac D, Ellis CR, Polaha J, Bylund DB (2006). Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. Am J Med Genet B Neuropsychiatr Genet 141:877-884.
25. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, et al. (1999). Haplotype relative risk study of catechol-O- methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 88:497-502.
26. Estes KS, Simpkins JW (1980). Age-related alterations in catecholamine concentrations in discrete preoptic area and hypothalamic regions in the male rat. Brain Res 194:556-560.
27. Faraone SV, Khan SA (2006). Candidate gene studies of attention-deficit/ hyperactivity disorder. J Clin Psychiatry 67 (Suppl 8):13-20.
28. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323.
29. Feng Y, Crosbie J, Wigg K, Pathare T, Ickowicz A, Schachar R, et al. (2005a). The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry 10:998-1005,973.
30. Feng Y, Wigg KG, Makkar R, Ickowicz A, Pathare T, Tannock R, et al. (2005b). Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). Am J Med Genet B Neuropsychiatr Genet 139:1 -6.
31. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL, et al. (2002). A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 70:1183-1196.
32. Friedel S, Saar K, Sauer S, Dempfle A, Walitza S, Renner T, et al. (2007). Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol Psychiatry 12:923-933.
33. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. (2002). The structure of haplotype blocks in the human genome. Science 296:2225-2229.
34. Gauderman WJ (2002). Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155:478-484.
35. Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS (2005). A genome- wide scalable SNP genotyping assay using microarray technology. Nat Genet 37:549-554.
36. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, Greenwood T, et al. (2003). Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8:299-308.
37. Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M (2000). No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Genet 96:282-284.
38. Hazell PL, Stuart JE (2003). A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry 42:886-894.
39. Hebebrand J, Dempfle A, Saar K, Thiele H, Herpertz-Dahlmann B, Linder M, et al. (2006). A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry! 1:196-205.
40. Heiser P, Dempfle A, Friedel S, Konrad K, Hinney A, Kiefl H, et al. (2007). Family-based association study of serotonergic candidate genes and attention-deficit/hyperactivity disorder in a German sample. J Neural Transm 114:513-521.
41. Hirasawa A, Shibata K, Horie K, Takei Y, Obika K, Tanaka T, et al. (1995). Cloning, functional expression and tissue distribution of human alpha 1 c-adrenoceptor splice variants. FEBS Lett 363:256-260.
42. Hollingshead A (1975). Four factor index of social status. New Haven.
43. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW (2005). Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65:529-534.
44. Kereszturi E, Kiraly O, Csapo Z, Tarnok Z, Gadoros J, Sasvari-Szekely M, Nemoda Z (2007). Association between the 120-bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: genetic and molecular analyses. Am J Med Genet B Neuropsychiatr Genet 144:231-236.
45. Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P, et al. (2005). The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med 47:565-572.
46. Kim JW, Biederman J, Arbeitman L, Fagerness J, Doyle AE, Petty C, et al. (2007). Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 144:781-790.
47. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, et al. (2002). Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 27:607-619.
48. Kustanovich V, Merriman B, McGough J, McCracken JT, Smalley SL, Nelson SF (2003). Biased paternal transmission of SNAP-25 risk alleles in attention- deficit hyperactivity disorder. Mol Psychiatry 8:309-315.
49. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatry disorders. Pharmacogenetics 6:243-250.
50. Lee JJ, Chang CK, Liu IM, Chi TC, Yu HJ, Cheng JT (2001). Changes in endogenous monoamines in aged rats. Clin Exp Pharmacol Physiol 28:285-289.
51. Levitan RD, Masellis M, Basile VS, Lam RW, Jain U, Kaplan AS, et al. (2002). Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder. J Affect Disord 71:229-233.
52. D, Sham PC, Owen MJ, He L (2006a). Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15:2276-2284.
53. J, Kang C, Wang Y, Zhou R, Wang B, Guan L, et al. (2006b). Contribution of 5-HT2A receptor gene -1438A G polymorphism to outcome of attention- deficit/hyperactivity disorder in adolescents. Am J Med Genet B Neuro psychiatr Genet 141:473-476.
54. J, Wang Y, Zhou R, Wang B, Zhang H, Yang L, Faraone SV (2006c). Association of attention-deficit/hyperactivity disorder with serotonin 4 receptor gene polymorphisms in Han Chinese subjects. Neurosci Lett 401:6-9.
55. J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, Faraone SV (2006d). Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/hyperactivity disorder in Han Chinese subjects. Neurosci Lett 407:107-111.
56. J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, Faraone SV (2007). Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 144:14-19.
57. Manor I, Kotler M, Sever Y, Eisenberg J, Cohen H, Ebstein RP, Tyano S (2000). Failure to replicate an association between the catechol-O- methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am J Med Genet 96:858-860.
58. McKinney C, Merriman TR (2007). The human genome and understanding of common disease: present and future technologies. Cell Mol Life Sci 64:961-978.
59. Mick E, Faraone SV (2008). Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17:261 -284,vii-viii.
60. Mill J, Curran S, Kent L, Gould A, Huckett L, Richards S, et al. (2002). Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. Am J Med Genet 114:269-271.
61. Mill J, Richards S, Knight J, Curran S, Taylor E, Asherson P (2004). Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry 9:801 -810.
62. Mill J, Xu X, Ronald A, Curran S, Price T, Knight J, et al. (2005). Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B. Am J Med Genet B Neuropsychiatr Genet 133:68-73.
63. Mills S, Langley K, Van den Bree M, Street E, Tunc D, Owen MJ, et al. (2004). No evidence of association between catechol-O-methyltransferase (COMT) Val158Met genotype and performance on neuropsychological tasks in children with ADHD: a case-control study. BMC Psychiatry 4:15.
64. Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Mailer JB, et al. (2008). Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B:1337-1344.
65. Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD (2007). Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry 61:1320-1328
66. Ogdie MN, Bakker SC, Fisher SE, Francks C, Yang MH, Cantor RM, et al. (2006). Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Mol Psychiatry 11:5-8.
67. Ogdie MN, Fisher SE, Yang M, Ishii J, Francks C, Loo SK, et al. (2004). Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am J Hum Genet 75:661-668.
68. Ogdie MN, Macphie IL, Minassian SL, Yang M, Fisher SE, Francks C, et al. (2003). A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am J Hum Genet 72:1268-1279.
69. Payton A, Holmes J, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, et al. (2001). Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet 105:464-470.
70. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942-948.
71. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. (2007). PLINK: a tool set for whole-genome association and population- based linkage analyses. Am J Hum Genet 81:559-575.
72. Puumala T, Riekkinen P Sr, Sirvio J (1997). Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat. Pharmacol Biochem Behav 56:705-712.
73. Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, Faraone SV (2003). Family-based and case-control association studies of catechol-O- methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet B Neuropsychiatr Genet 118:103-109.
74. Quist JF, Barr CL, Schachar R, Roberts W, Malone M, Tannock R, et al. (2000). Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 5:537-541.
75. Riederer P, Wuketich S (1976). Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 38:277-301.
76. Romanos M, Freitag C, Jacob C, Craig DW, Dempfle A, Nguyen TT, et al. (2008). Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol Psychiatry 13:522-530.
77. Sengupta SM, Grizenko N, Schmitz N, Schwartz G, Ben Amor L, Bellingham J, et al. (2006). COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD. J Am Acad Child Adolesc Psychiatry 45:1363-1369.
78. Sirvio J, MacDonald E (1999). Central alphal -adrenoceptors: their role in the modulation of attention and memory formation. Pharmacol Ther 83:49-65.
79. Smalley S, Kustanovich V, Minassian SL, Stone JL, Ogdie MN, et al. (2002). Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Hum Genet 71:959-963.
80. Spitzer RL, Endicott J, Robins E (1978). Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35:773-782.
81. Steemers FJ, Chang W, Lee G, Barker DL, Shen R, Gunderson KL (2006). Whole-genome genotyping with the single-base extension assay. Waf Methods 3:31-33.
82. Stramentinoli G, Gualano M, Algeri S, de Gaetano G, Rossi EC (1978). Catechol- O-methyl transferase (COMT) in human and rat platelets. Thromb Haemost 39:238-239.
83. Strine TW, Lesesne CA, Okoro CA, McGuire LC, Chapman DP, Balluz LS, Mokdad AH (2006). Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit/ hyperactivity disorder. Prev Chronic Dis 3:A52.
84. Taerk E, Grizenko N, Ben Amor L, Lageix P, Mbekou V, Deguzman R, et al. (2004). Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD. BMC Med Genet 5:30.
85. Tahir E, Curran S, Yazgan Y, Ozbay F, Cirakoglu B, Asherson PJ (2000). No association between low- and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Am J Med Genet 96:285-288.
86. Thapar A, Langley K, Fowler T, Rice F, Turic D, Whittinger N, et al. (2005). Catechol o-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/ hyperactivity disorder. Arch Gen Psychiatry 62:1275-1278.
87. Turic D, Williams H, Langley K, Owen M, Thapar A, O'Donovan MC (2005). A family based study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD). Am J Med Genet B Neuropsychiatr Genet 133:64-67.
88. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106.
89. Xu X, Mill J, Zhou K, Brookes K, Chen CK, Asherson P (2007). Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. Am J Med Genet B Neuropsychiatr Genet 144:83-86.
90. Zhou K, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, et al. (2008). Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B: 1392-1398.
91. Zoroglu SS, Erdal ME, Erdal N, Ozen S, Alasehirli B, Sivasli E (2003). No evidence for an association between the T102C and 1438 G/A polymorphisms of the serotonin 2A receptor gene in attention deficit/hyperactivity disorder in a Turkish population. Neuropsychobiology 47:17-20.